Completed PHASE1 INTERVENTIONAL 1-arm NCT01582412

Drug Interaction Study of Isavuconazole and Digoxin

A Phase 1, Open-Label, Sequential Study of the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Digoxin in Healthy Adult Subjects

Sponsor: Astellas Pharma Global Development, Inc.

Conditions Healthy Volunteers Pharmacokinetics of Digoxin Pharmacokinetics of Isavuconazole

Interventions Isavuconazole digoxin

Updated 6 times since 2017 Last updated: Aug 31, 2015 Started: Mar 31, 2012 Primary completion: May 31, 2012 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01582412, this PHASE1 trial focuses on Healthy Volunteers and Pharmacokinetics of Digoxin and remains completed. Sponsored by Astellas Pharma Global Development, Inc., it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Astellas Pharma Global Development, Inc.
Basilea Pharmaceutica International Ltd

Data source: Astellas Pharma Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States